FNEHIN - First Nations Environmental Health Innovation Network

Expertise:

Tuberculosis in Aboriginal Peoples and the Foreign-born; public health

Focus:

All aspects of tuberculosis including Social Determinants of Tuberculosis. For example: Housing, Indoor Air Quality etc.

Affiliations:

Professor: Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB. Adjunct Professor: Department of Public Health Sciences, School of Public Health. Member: Pulmonary Division, Department of Medicine, University of Alberta, Edmonton, AB. Consultant, Tuberculosis: Provincial TB Clinic, Alberta Health Services, Edmonton. Consultant, Tuberculosis: Edmonton TB Clinic, Edmonton Zone, Alberta. Consultant, Tuberculosis: First Nations and Inuit Health, Alberta, Saskatchewan and Manitoba Regions; First Nations and Inuit Health Branch, Health Canada. Director: Tuberculosis Program Evaluation and Research Unit, University of Alberta, Edmonton, AB.

Academic Supervisor (if Applicable)

Research Area(s)

Housing, Indoor Air Quality

Geographical Preference(s)

Alberta, Manitoba, Saskatchewan

Projects

• Ediatric tuberculosis in Alberta: epidemiology and case characteristics (1990-2004).
• Why internationally adopted children should be screened for tuberculosis
• Mycobacterium tuberculosis infection in First Nations preschool children in Alberta: implications for BCG (bacille Calmette-Gu
• Physician experience, public health and the management of tuberculosis
• Tuberculosis: still overlooked as a cause of community-acquired pneumonia--how not to miss it.
• Bronchial anthracofibrosis and tuberculosis: CT features before and after treatment
• Pediatric tuberculosis in Alberta First Nations (1991-2000): outbreaks and the protective effect of bacille Calmette-Gu
• Tuberculosis and malnutrition
• Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment
• Recommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts
• Guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arriving in Canada: a summary
• Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection
• Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management.
• Latent tuberculosis treatment
• Tuberculosis control in Alberta. A federal, provincial and regional public health partnership.
• Access to health research: Participation and empowerment of aboriginal peoples in research to improve health and well-being
• The determinants of tuberculosis transmission in the Canadian-born population of the prairie provinces
• Randomized clinical trial of 4 months rifampin vs 9 months INH for the treatment of latent TB